Day: November 8, 2019

MADRID, Espanha, Nov. 08, 2019 (GLOBE NEWSWIRE) — A Ria Money Transfer, subsidiária da Euronet Worldwide, Inc. (NASDAQ: EEFT) e líder global no setor de transferência de dinheiro, anunciou hoje uma parceria de quatro anos com o Atlético de Madrid, tornando-se o novo patrocinador do clube e parceiro oficial de transferência de dinheiro. A partir desta temporada, a camisa com a marca Ria será usada pelas primeiras equipes do clube em todas os jogos domésticos até 2023.Para oficializar o acordo, representantes da Ria visitaram o Estádio Wanda Metropolitano em Madrid, onde Enrique Cerezo, presidente do Atlético de Madrid, revelou a nova camisa oficial.Através desta parceria, a Ria será capaz de fomentar uma relação mais estreita com a base de torcedores diversificada e generalizada do Atlético de Madrid, que ressoa com a pegada global...

WASHINGTON, Nov. 08, 2019 (GLOBE NEWSWIRE) — Today, U. S. Steel Tubular Products, Inc., a subsidiary of United States Steel Corporation (NYSE: X), announced that Vicki Hollub, president and chief executive officer of Occidental Petroleum Corporation, is the recipient of the Chief Roughneck Award for 2019.  The announcement was made at the 90th annual meeting of the Independent Petroleum Association of America (IPAA).U. S. Steel Senior Vice President – Industrial, Service Center, Mining Solutions and Tubular Operations Douglas R. Matthews presented Ms. Hollub with the traditional Chief Roughneck bronze bust and hard hat. “Vicki’s enthusiastic quest for excellence and her unflagging support of people and communities truly epitomize the spirit of the Chief Roughneck Award,” said Matthews.Vicki Hollub is President and Chief Executive...

ROBIT PLC     STOCK EXCHANGE RELEASE                   8 November 2019 AT 21.35Repurchase of own shares on 8 November 2019In the Nasdaq HelsinkiROBIT now holds a total of 168 090 own shares (ROBIT) including the shares repurchased on 8 November 2019.ROBIT PLCIlkka MiettinenAttachmentTrades 081119

Robit Oyj                              PÖRSSITIEDOTE                  8.11.2019 klo 21.35Omien osakkeiden hankinta 8.11.2019Helsingin PörssiYhtiön hallussa on 8.11.2019 tehtyjen kauppojen jälkeen 168 090 osaketta.ROBIT OYJIlkka MiettinenRepurchase of own shares on 8 November 2019LiiteKaupat 081119

EURO RESSOURCES REPORTS EARNINGS FOR THETHIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2019Paris, France, November 8, 2019:  EURO Ressources S.A. (“EURO” or “the Company”) (Paris: EUR) today announced its unaudited statutory interim financial results prepared in accordance with International Financial Reporting Standards (“IFRS”) for the nine months ended September 30, 2019.  These unaudited interim financial statements were approved by the Board of Directors on November 8, 2019.  All financial amounts are expressed in Euros (“€” or “euros”) unless otherwise specified.HighlightsUnder IFRS, EURO reported a net profit of €3.5 million (€0.056 per share) and €11.7 million (€0.187 per share) for the three and nine months ended September 30, 2019, respectively, compared to €3.2 million (€0.052 per share) and €10.9 million (€0.175 per share)...

EURO RESSOURCES ANNONCE SES RÉSULTATS POUR LETROISIÈME TRIMESTRE ET LES NEUF MOIS CLOS LE 30 SEPTEMBRE 2019Paris, France, le 8 novembre 2019 : EURO Ressources S.A. (« EURO » ou la « Société ») (Paris : EUR) a publié aujourd’hui ses résultats financiers intermédiaires non audités, préparés conformément aux Normes internationales d’information financière (« IFRS ») pour la période de neuf mois close le 30 septembre 2019. Ces états financiers intermédiaires non audités ont été approuvés par le Conseil d’administration le 8 novembre 2019. Sauf mention contraire, tous les montants sont exprimés en euros (« € »).Faits marquantsSelon les IFRS, EURO a fait état d’un bénéfice net de respectivement 3,5 millions d’euros (0,056 € par action) et de 11,7 millions d’euros (0,187 € par action) pour le trimestre et les neuf...

Roxadustat cardiovascular safety comparable to placebo in non-dialysis dependent (NDD) patients, as assessed by Major Adverse Cardiovascular Events (MACE) and MACE+Roxadustat did not increase risk of MACE and reduced risk of MACE+ compared to epoetin alfa in dialysis-dependent (DD) patients;Roxadustat reduced risk of MACE by 30% and MACE+ by 34% compared to epoetin alfa in the incident dialysis (ID) patient subgroup of the DD populationRoxadustat achieved primary efficacy endpoints in NDD and DD patientsWASHINGTON, Nov. 08, 2019 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ:FGEN), today announced results from the pooled analyses of data from six global pivotal Phase 3 trials investigating roxadustat, a first-in-class, orally-administered inhibitor of hypoxia-inducible-factor (HIF) prolyl hydroxylase activity. The pooled analyses assessed...

 COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSEPOINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSEParis et Boston, le 8 novembre 2019 – 20 : 00 pm CET – Néovacs analyse les mesures requises pour sauvegarder les intérêts de la Société et de ses actionnaires compte tenu de son niveau de trésorerie (cf. communiqué du 2 octobre 2019), de la baisse significative du cours de bourse intervenue au cours de ces dernières semaines, rendant difficile l’utilisation du programme de financement en ORNANE et de l’absence de solution de financement durable à date.Dans ces conditions, la Société a demandé à Euronext Paris la suspension de la cotation de son titre (ISIN : FR0004032746) et des bons de souscription d’actions « Neovacs 2017 » (ISIN : FR0013275971), à compter de ce jour et jusqu’à...

TORONTO, Nov. 08, 2019 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A) (“Dundee” or the “Company”) senior management will host a conference call on Friday, November 15, 2019 at 10 a.m. ET to discuss the Company’s third quarter 2019 results.THIRD QUARTER 2019 RESULTS CONFERENCE CALL AND WEBCAST

GAUMONTInformations relatives au nombre total de droits de vote et d’actions du capital socialprévues par l’article L. 233-8-II du code de commerceet l’article 223-16 du règlement général de l’Autorité des marchés financiersLe 8 novembre 2019Pièce jointeversion pdf